Literature DB >> 3382304

Physician knowledge, attitudes, and behavior related to reporting adverse drug events.

A S Rogers1, E Israel, C R Smith, D Levine, A M McBean, C Valente, G Faich.   

Abstract

Voluntary physician reporting of adverse drug events (ADEs) in their patients remains the single most important source of information on serious and rare ADEs. Yet, substantial underreporting exists and the factors producing it are unclear. We surveyed 3000 randomly chosen physicians by mailed questionnaire to determine their knowledge about the reporting system, attitudes toward reporting, and their past behavior in reporting the ADEs they had detected. Responses numbered 1121. Only 57% were aware of the Food and Drug Administration's reporting system. While 418 physicians had detected an ADE in their practices during the previous year, only 21 physicians reported these events directly to the Food and Drug Administration. The physicians appear to appreciate the safety issues involved in prescription drug use and view reporting as a professional obligation; however, the current reporting system is considered inconvenient.

Entities:  

Mesh:

Year:  1988        PMID: 3382304

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  36 in total

1.  Attitudinal survey of voluntary reporting of adverse drug reactions.

Authors:  I A Eland; K J Belton; A C van Grootheest; A P Meiners; M D Rawlins; B H Stricker
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

2.  RADARx: Recognizing, Assessing, and Documenting Adverse Rx events.

Authors:  S Brown; K Black; S Mrochek; A Wood; T Bess; J Cobb; J Francis
Journal:  Proc AMIA Symp       Date:  2000

3.  Reporting of adverse drug reactions by poison control centres in the US.

Authors:  P A Chyka; S W McCommon
Journal:  Drug Saf       Date:  2000-07       Impact factor: 5.606

4.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

5.  Attitudes to adverse drug reaction reporting in the Northern Region.

Authors:  D N Bateman; G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

6.  Adverse event reporting for herbal medicines: a result of market forces.

Authors:  Rishma Walji; Heather Boon; Joanne Barnes; Zubin Austin; G Ross Baker; Sandy Welsh
Journal:  Healthc Policy       Date:  2009-05

7.  Propylthiouracil-induced hepatotoxicity and death. Hopefully, never more.

Authors:  Saul Malozowski; Ana Chiesa
Journal:  J Clin Endocrinol Metab       Date:  2010-07       Impact factor: 5.958

8.  Computerized surveillance of adverse drug events in hospital patients. 1991.

Authors:  D C Classen; S L Pestotnik; R S Evans; J P Burke
Journal:  Qual Saf Health Care       Date:  2005-06

9.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

10.  Influence of pharmacists' attitudes on adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; J J Gestal-Otero
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.